Danone announces intention to sue Fonterra

<p>Fonterra is to defend itself against a legal case by Danone.</p>

Danone has announced it is going to sue Fonterra over baby formula recalls in 2013.

In August, Fonterra's products were infected by a botulism-causing bacteria and Danone uses these ingredients within its own range.

Fonterra said in a statement it "will vigorously defend any proceedings", although the product recalls turned out to be a false alarm.

"This affair illustrates serious failings on Fonterra's part in applying the quality standards required in the food industry," Danone said in a statement.

Danone lowered its full-year targets for 2013 as a result of the fallout from the botulism scare.

The share price of Danone has fallen today (January 9th) on the back of the announcement it is planning to sue New Zealand company Fonterra.

By 11:09 GMT, stocks were 0.66 per cent lower on the main Paris stock exchange when compared to the share price at the start of the day.

Find up to date information on the FTSE 100 and spread betting strategies at City Index

Build your confidence risk free
Join our live webinars for the latest analysis and trading ideas. Register now

StoneX Financial Ltd (trading as “City Index”) is an execution-only service provider. This material, whether or not it states any opinions, is for general information purposes only and it does not take into account your personal circumstances or objectives. This material has been prepared using the thoughts and opinions of the author and these may change. However, City Index does not plan to provide further updates to any material once published and it is not under any obligation to keep this material up to date. This material is short term in nature and may only relate to facts and circumstances existing at a specific time or day. Nothing in this material is (or should be considered to be) financial, investment, legal, tax or other advice and no reliance should be placed on it.

No opinion given in this material constitutes a recommendation by City Index or the author that any particular investment, security, transaction or investment strategy is suitable for any specific person. The material has not been prepared in accordance with legal requirements designed to promote the independence of investment research. Although City Index is not specifically prevented from dealing before providing this material, City Index does not seek to take advantage of the material prior to its dissemination. This material is not intended for distribution to, or use by, any person in any country or jurisdiction where such distribution or use would be contrary to local law or regulation.

For further details see our full non-independent research disclaimer and quarterly summary.